PD34-08 ASSOCIATION BETWEEN DISEASE INDICATION AND STEROID USE AND MINERALOCORTICOID-RELATED TOXICITY OF ABIRATERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATE CANCER: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS

Mary K. Hall,Whitney Padgett,Zachary Klaassen,Diana Magee,Aaron A. Laviana,Amy N. Luckenbaugh,Raj Satkunasivam,Christopher J.D. Wallis

PD34-08 ASSOCIATION BETWEEN DISEASE INDICATION AND STEROID USE AND MINERALOCORTICOID-RELATED TOXICITY OF ABIRATERONE ACETATE IN PATIENTS WITH ADVANCED PROSTATE CANCER: A META-ANALYSIS OF RANDOMIZED CONTROL TRIALS

2021

Mary K. Hall
Whitney Padgett
Zachary Klaassen
Diana Magee
Aaron A. Laviana
Amy N. Luckenbaugh
Raj Satkunasivam
Christopher J.D. Wallis

INTRODUCTION AND OBJECTIVE:Abiraterone acetate (AA) has proven survival benefit for patients with metastatic hormone sensitive prostate cancer (mHSPC) and metastatic castrate resistant prostate can...

Keywords:

Mineralocorticoid
Randomized controlled trial
Disease
Prostate cancer
Oncology
Internal medicine
in patient
Medicine
Toxicity
Meta-analysis
Abiraterone acetate

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations